Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Shares of IQVIA Holdings, Inc. (IQV), a provider of clinical research services and healthcare data analytics, traded lower following the company’s fourth quarter earnings release. Management noted that...
— Gary H. Miller
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on IQVIA Holdings Inc.
IQVIA Holdings ($IQV), representing 6.9% of the fund's assets, is a leading provider of data analytics, technology solutions, and outsourced clinical research services to the life sciences and healthcare industries. The manager maintains...
IQVIA Holdings ($IQV), representing 3.3% of the fund's net assets, is a leading global provider of advanced data analytics, clinical research services, and technology infrastructure to life sciences and biopharmaceutical enterprises. The manager holds...
IQVIA Holdings ($IQV) is a global leader in clinical research outsourcing, advanced healthcare analytics, and pharmaceutical commercial intelligence. Broyhill holds a...
More institutional theses from Sycamore Mid Cap Value Equity
The company posted solid earnings driven by robust demand in advanced semiconductor manufacturing and AI applications. Management refinanced its...
The company benefited from a constructive nitrogen pricing backdrop, low customer inventories, and tight global supply. Disruptions in the...
The company reported strong earnings and guidance driven by robust demand from data centers and AI infrastructure. Rising revenues, margins,...